Treatment Options

Dr. Conaghan's picture
November 21, 2015

In the embryology lab we track “implantation rates” closely for all the patients we treat.  It’s the number of embryos that implant in the uterus after transfer, divided by the total number of embryos transferred.  When we perform genetic testing on embryos, we can get implantation rates of 50-70% or more regardless of the age of the patient, but only if the patient has a chromosomally normal embryo.  With increasing maternal age, the likelihood of having a normal embryo decreases because older mothers have fewer eggs, and in older age groups such as age 42 and above, as few as 10% of the embryos will have the correct number of chromosomes.

Dr. Givens's picture
May 13, 2015

Every few years, a new technological development comes along in our field—one creating such an impact, that it eventually becomes nearly ubiquitous. The last time this happened was in 1993 when intracytoplasmic sperm injection (ICSI) allowed men with severe male factor to become biological fathers.

In 2015, the breakthrough of the decade is clearly the ability to diagnose embryos for the presence or absence of all 23 pairs of chromosomes, what we call comprehensive chromosomal screening (CCS). This year’s Pacific Coast Reproductive Society (PCRS) meeting was dominated by this topic, and appropriately so. There is no doubt in my mind that this has been the most important innovation in in vitro fertilization (IVF) since the advent of ICSI.

PFC Team's picture
February 20, 2015

San Francisco, CA – February 20, 2015 – On February 2, 2015, the Pacific Fertility Egg Bank celebrated its 100th embryo transfer, reaching a significant juncture in the history of the bank, which opened in August of 2012, making it the first freestanding egg bank in Northern California. “This has been a labor of love,” said Daragh Castenada, program director of PFC’s Egg Donor Agency and the Pacific Fertility Egg Bank. “We’re all incredibly excited about this milestone.”

In 2007, PFC was among the first to begin using new egg-freezing technology (vitrification), which paved the way for the launch of its frozen donor egg bank. However, it first spent several years refining laboratory techniques to ensure the best of outcomes for patients.

PFC Team's picture
January 27, 2015

Comprehensive chromosome screening (CCS) is one of many cutting-edge technologies Pacific Fertility Center (PFC) offers. This type of screening doesn’t just look for one type of genetic disease. Using highly sensitive molecular genetic techniques, CCS reliably detects all 23 pairs of chromosomes. Embryos with normal chromosomes, euploid embryos, produce very high pregnancy rates at very low risk.

CCS can benefit you in many ways.

By identifying embryos with missing or extra chromosomes, CCS reduces miscarriage and chromosomal abnormalities such as Down syndrome. 

Selecting the healthiest embryos, CCS improves implantation, pregnancy rates, and the health of babies. It also allows for transfer of a single embryo, which reduces risks linked to multiple gestation.

May 16, 2014

PFC's Dr. Eldon Schriock, a longtime advocate of fertility services for the LGBTQ community, was interviewed for The Bay Area Reporter's story, "Hopeful moms see fertility options." The story focuses on family building for lesbian women and the LGBTQ community.

Read the full story here.